Skip to content

Primary Prevention of Cardiovascular Diseases in Childhood and Adolescence: the Role of Physical Activity

Outpatient Strategy of Primary Prevention of Cardiovascular Diseases in Childhood and Adolescence: the Role of Physical Activity

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01580319
Enrollment
27
Registered
2012-04-19
Start date
2009-04-30
Completion date
2011-12-31
Last updated
2012-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Blood Pressure, Hypercholesterolemia, Obesity, Sedentary Lifestyle

Keywords

obesity, cholesterol, cholesterol, LDL, cholesterol, HDL, blood glucose, Triglyceride, C-Reactive Protein - hs, blood pressure, physical activity, Sedentary Lifestyle

Brief summary

This research project is about a physical activity intervention in pediatric outpatients to try control and prevent heart diseases such as hypertension, obesity, high cholesterol.

Detailed description

Control Group: receive information about health lifestyle Interventional Group: receive a structured plan with exercises to do 3 times per week within 50 minutes. It is a randomized clinical trial and population are children and adolescents.

Interventions

OTHERphysical exercise

150 minutes per week

Sponsors

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
CollaboratorOTHER
Instituto de Cardiologia do Rio Grande do Sul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* 6 to 17 years * obesity * high cholesterol

Exclusion criteria

* congenital heart diseases * less than 6 or more than 17 years old

Design outcomes

Primary

MeasureTime frameDescription
Reduction on risk factors for a cardiovascular diseases (reduction on BMI, cholesterol, LDL, glucose, high-sensitivity C-reactive protein, blood pressure and/or increase on HDL)These measurement were taken at end of followup (27th week)These measurement (taken at end of study) are assessed for a external research (blind for randomization) to judge the individual outcome.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026